AI Visibility Scorecard
Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy
breyanzi.com · Healthcare
Borderline visible. AI bots can crawl Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 6 times
Claude · Apple Intelligence · ChatGPT
#47,819 of 925,301 in Healthcare for AI visibility
30
AI Naming Predictability
iRarely named · 30/100
Healthcare average 11
Top 6% of Healthcare
See what's behind this score →4
-
Network Authority
iNot connected yet
Healthcare average 0.0
0 relationships · Healthcare average 3
See what's behind this score →5
0
About Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy
from our crawl and measurement
"Breyanzi® (lisocabtagene maraleucel) CAR T cell therapy treatment is a one-time infusion used to treat adult patients with large B-cell lymphoma (LBCL), chronic lymphocytic leukemia (CLL)." That is how Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy introduces itself. To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 4.2 out of 10.
Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.
AI crawlers have visited 5 times in our tracking, including ClaudeBot (Anthropic), GPTBot (ChatGPT) and Applebot (Siri).
- Company ·
- Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy
- Website ·
- breyanzi.com
- Industry ·
- Healthcare
- Site status ·
- Live (The website showed an active business site when last checked (Oct 31, 2026).)
- Last scored ·
- Aug 1, 2026
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 4.2/10, Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Company Named by ChatGPT, Gemini, and Claude
When a buyer asks ChatGPT which company to use, two different things can happen. ChatGPT can name a company in its answer. Or it can link to a web page as a source. Most advice about AI visibility is about the second one. Our data says the first one is what matters.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy.
Source & Attribution
Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/breyanzi
Cite this score: Engagemii (2026). "AEO Score for Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy." Retrieved from https://engagemii.com/aeo/brands/breyanzi
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform